The global low-density lipoprotein (LDL) test market is poised for rapid growth, fueled by the alarming statistics reported by the Centers for Disease Control and Prevention. With a staggering 71 million Americans exhibiting high levels of LDL cholesterol, effective testing and management become paramount. However, only a fraction of those affected have their LDL cholesterol under control. This pressing need for improved cholesterol management and risk assessment has spurred the expansion of the LDL test market. As chronic diseases such as cardiovascular conditions continue to rise, the introduction of LDL testing stands as a vital response within the healthcare landscape.
According to Data Bridge Market Research the Global Low-Density Lipoprotein (LDL) Test Market which is USD 8,575.99 million in 2022, is expected to reach USD 13,772.33 million by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030.
“Escalating prevalence of chronic diseases drive the market growth”
The global low-density lipoprotein (LDL) test market is driven by the escalating prevalence of chronic diseases. Conditions such as cardiovascular diseases, diabetes, and obesity have reached epidemic proportions worldwide, emphasizing the need for effective risk assessment and management. LDL cholesterol, often referred to as "bad" cholesterol, is a crucial biomarker in evaluating cardiovascular health. As awareness of the link between elevated LDL levels and chronic diseases grows, the demand for accurate LDL testing rises, propelling the growth of the global LDL test market.
What restraints the growth of the global low-density lipoprotein (LDL) test market?
“Shortage of skilled professionals”
The global low-density lipoprotein (LDL) test market faces a significant restraint due to a shortage of skilled professionals. The accurate and reliable interpretation of LDL test results requires specialized expertise in medical diagnostics and laboratory practices. With a limited pool of qualified professionals, the capacity to conduct precise testing, ensure proper quality control, and deliver accurate patient outcomes may be compromised. This challenge hinders the efficient functioning and growth potential of the LDL test market on a global scale.
Segmentation: Global Low-Density Lipoprotein (LDL) Test Market
The low-density lipoprotein (LDL) test market is segmented on the basis of type, component, disease, end user, and distribution channel.
- On the basis of type, the low-density lipoprotein (LDL) test market is segmented into LDL-C, LDL-P, LDL-B, and others.
- On the basis of component, the low-density lipoprotein (LDL) test market is segmented into kits and reagents, devices, and services.
- On the basis of disease, the low-density lipoprotein (LDL) test market is segmented into diabetes, stroke, atherosclerosis, obesity, dyslipidaemia, carotid artery disease, peripheral arterial disease, angina, and others.
- On the basis of distribution channel, the low-density lipoprotein (LDL) test market is segmented into direct tenders, retail.
- On the basis of end user, the low-density lipoprotein (LDL) test market is segmented into hospitals, clinics, ambulatory care, research laboratory, and others.
Regional Insights: North America dominates the Global Low-Density Lipoprotein (LDL) Test Market
North America's stronghold in the low-density lipoprotein (LDL) test market is attributed to its elevated burden of cardiovascular diseases. With a higher prevalence of heart-related conditions, the region's healthcare focus on diagnosis and management fuels the demand for LDL testing. The growing emphasis on preventive healthcare practices further propels market expansion, as individuals seek early detection and intervention to mitigate cardiovascular risks, reinforcing North America's leading position.
Asia-Pacific is poised for robust growth in the LDL test market, driven by multiple factors. Escalating chronic disease rates, particularly cardiovascular ailments, stimulate demand for accurate diagnostic tools such as LDL tests. Improved healthcare infrastructure and access to quality medical services contribute to heightened diagnosis and treatment rates. The region's aging population and changing dietary patterns, characterized by a surge in junk food consumption, amplify the demand for LDL testing, positioning Asia-Pacific for significant market growth.
To know more about the study visit, https://www.databridgemarketresearch.com/jp/reports/global-ldl-test-market
Recent Developments in Global Low-Density Lipoprotein (LDL) Test Market
- In 2021, Verichem unveiled its Ready-to-Use HDL/LDL Calibration Verification Kit, catering to diverse clinical laboratory professionals. This comprehensive solution serves routine diagnostics, medical research, and in-vitro diagnostic (IVD) product development. Designed to ensure accuracy and reliability, the kit facilitates precise calibration and verification processes, aligning with the stringent quality requirements of the healthcare industry.
The Prominent Key Players Operating in the Global Low-Density Lipoprotein (LDL) Test Market Include:
- Thermo Fisher Scientific Inc. (U.S.)
- BD (U.S.)
- Abbott (U.S.)
- QIAGEN (Germany)
- Quest Diagnostics Incorporated (U.S.)
- Sekisui Diagnostics (U.S.)
- Express Biotech International (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Randox Laboratories Ltd. (England)
- Diasys Diagnostic Systems GmbH (Germany)
- Reckondiagnostics (India)
- Eurolyser Diagnostica GmbH (Austria)
- Diazyme Laboratories, Inc. (Germany)
- Laboratory Corporation of America Holdings. (U.S.)
- Cell Biolabs, Inc. (U.S.)
- Atlas Medical GmbH (U.K.)
- Eurofins Scientific (Luxembourg)
- Home Access Health (U.S.)
- Clinical Reference Laboratory, Inc. (U.S.)
- Merck KGaA (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of global low-density lipoprotein (LDL) test market companies contact, https://www.databridgemarketresearch.com/jp/contact
Research Methodology: Global Low-Density Lipoprotein (LDL) Test Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
